These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1883797
1. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Chamberlain G, Freeman R, Price F, Kennedy A, Green D, Eve L. Br J Obstet Gynaecol; 1991 Jul; 98(7):707-11. PubMed ID: 1883797 [Abstract] [Full Text] [Related]
2. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. Bonnar J, Sheppard BL. BMJ; 1996 Sep 07; 313(7057):579-82. PubMed ID: 8806245 [Abstract] [Full Text] [Related]
5. Long-term treatment of menorrhagia with mefenamic acid. Fraser IS, McCarron G, Markham R, Robinson M, Smyth E. Obstet Gynecol; 1983 Jan 07; 61(1):109-12. PubMed ID: 6337354 [Abstract] [Full Text] [Related]
6. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Dockeray CJ, Sheppard BL, Bonnar J. Br J Obstet Gynaecol; 1989 Jul 07; 96(7):840-4. PubMed ID: 2765430 [Abstract] [Full Text] [Related]
8. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Harrison RF, Cambell S. Lancet; 1976 Aug 07; 2(7980):283-5. PubMed ID: 59855 [Abstract] [Full Text] [Related]
9. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. Reid PC, Virtanen-Kari S. BJOG; 2005 Aug 07; 112(8):1121-5. PubMed ID: 16045528 [Abstract] [Full Text] [Related]
10. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Hall P, Maclachlan N, Thorn N, Nudd MW, Taylor CG, Garrioch DB. Br J Obstet Gynaecol; 1987 Jun 07; 94(6):554-8. PubMed ID: 3304401 [Abstract] [Full Text] [Related]
11. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Cameron IT, Haining R, Lumsden MA, Thomas VR, Smith SK. Obstet Gynecol; 1990 Jul 07; 76(1):85-8. PubMed ID: 2359570 [Abstract] [Full Text] [Related]
12. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. Garay RP, Chiavaroli C, Hannaert P. Am J Ther; 2006 Jul 07; 13(3):236-47. PubMed ID: 16772766 [Abstract] [Full Text] [Related]
13. Antifibrinolytics for heavy menstrual bleeding. Lethaby A, Farquhar C, Cooke I. Cochrane Database Syst Rev; 2000 Jul 07; (4):CD000249. PubMed ID: 11034679 [Abstract] [Full Text] [Related]
14. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. van Eijkeren MA, Christiaens GC, Geuze HJ, Haspels AA, Sixma JJ. Am J Obstet Gynecol; 1992 May 07; 166(5):1419-28. PubMed ID: 1595797 [Abstract] [Full Text] [Related]
15. Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Grover V, Usha R, Gupta U, Kalra S. Asia Oceania J Obstet Gynaecol; 1990 Sep 07; 16(3):255-9. PubMed ID: 2088249 [Abstract] [Full Text] [Related]
16. Letter: Alleviation of IUD menorrhagia with ethamsylate. Harrison RF, Campbell S. Br Med J; 1976 Mar 13; 1(6010):649-50. PubMed ID: 766907 [Abstract] [Full Text] [Related]
17. Effectiveness of etamsylate in intrauterine-device menorrhagia. Kovács L, Annus J. Gynecol Invest; 1978 Mar 13; 9(4):161-5. PubMed ID: 374202 [Abstract] [Full Text] [Related]
18. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Anderson AB, Haynes PJ, Guillebaud J, Turnbull AC. Lancet; 1976 Apr 10; 1(7963):774-6. PubMed ID: 56590 [Abstract] [Full Text] [Related]